-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$331.20-7.67% Downside
United Therapeutics Corporation Frequently Asked Questions
-
What analysts cover United Therapeutics Corporation?
United Therapeutics Corporation has been rated by research analysts at Jefferies, Oppenheimer, UBS, Wells Fargo, Goldman Sachs, Argus Research in the past 90 days.